CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-21 | MURPHY JOHN RAYMOND Director | Purchase | +10,000 | $1.39 | $14K | 594,792 |
| 2023-03-16 | MURPHY JOHN RAYMOND Director | Purchase | +20,000 | $1.67 | $33K | 574,792 |
| 2023-02-10 | Pham Quang X CEO and Chairman | Grant or award | +25,000 | $1.94 | $49K | 3,300,000 |
| 2023-01-24 | WILSON GLYNN Director | Conversion | +50,000 | 50,000 | ||
| 2023-01-24 | WILSON GLYNN Director | Conversion · Convertible Promissory Note | −50,000 | 0 | ||
| 2023-01-24 | Szot Matthew K Chief Financial Officer | Grant or award | +50,000 | 500,000 | ||
| 2023-01-24 | MURPHY JOHN RAYMOND Director | Conversion | +514,792 | 554,792 | ||
| 2023-01-24 | MURPHY JOHN RAYMOND Director | Conversion · Convertible Promissory Note | −514,792 | 0 |
Page 5 of 5 · 88 trades